HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text All Versions of this Article: 2382041822v1 238/2/640    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Weber, M.-A. Articles by Delorme, S. Search for Related Content PubMed PubMed Citation Articles by Weber, M.-A. Articles by Delorme, S.

Pathologic Skeletal Muscle Perfusion in Patients with Myositis: Detection with Quantitative Contrast-enhanced US—Initial Results¹

¹ From the Department of Radiology, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany (M.A.W., M.K., M.E., H.U.K., S.D.); Departments of Dermatology (U.J.), Neurology (H.B.H., U.M.), and Neuroradiology (M.H.), University of Heidelberg, Heidelberg, Germany; and Department of Hematology, Oncology, and Rheumatology, Clinic for Internal Medicine V, University of Heidelberg and Center of Rheumatic Diseases, Baden-Baden, Germany (C.F.). From the 2004 RSNA Annual Meeting. Received October 20, 2004; revision requested December 27; revision received January 20, 2005; accepted February 21; final version accepted February 21. Address correspondence to M.A.W. (e-mail: m.a.weber{at}dkfz.de).

Purpose: To prospectively determine whether contrast material–enhanced ultrasonography (US) can depict inflammation-induced changes in muscle perfusion for patients suspected of having dermatomyositis or polymyositis and to compare these findings with those of magnetic resonance (MR) imaging and muscle biopsy.

Materials and Methods: Institutional review board approval and informed consent were obtained. Perfusion in skeletal muscles was quantified with contrast-enhanced intermittent power Doppler US by applying a modified model that analyzed the replenishment kinetics of microbubbles. In 22 patients (16 women, six men; mean age, 52 years ± 17) who were suspected of having myositis and in 10 healthy volunteers (two women, eight men; mean age, 28 years ± 4), contrast-enhanced US of the clinically affected right biceps muscle was performed to measure blood flow, blood volume, and blood flow velocity. Additionally, the right upper arm was examined with a 1.5-T unit by using three different MR imaging techniques. Findings were compared with the results of clinical examinations and muscle biopsy. Data for perfusion-related parameters obtained at contrast-enhanced US were analyzed by using a nonparametric Mann-Whitney U test.

Results: Eight patients had histologically confirmed myositis and showed significantly higher blood flow velocity (P = .01), blood flow (P = .001), and blood volume (P = .002) at contrast-enhanced US than did patients who did not have myositis. Blood flow velocity (P = .001) and blood flow (P = .002) were significantly higher in patients with myositis than in volunteers. An increase in signal intensity on T2-weighted MR images was found in all patients with myositis, while contrast material enhancement on fat-suppressed T1-weighted MR images was found in only four of seven patients with myositis.

Conclusion: Initial results show that contrast-enhanced US is a feasible method for noninvasively demonstrating increased perfusion in the involved muscle groups in patients with myositis.

© RSNA, 2005